BRKR Bruker Corp
533
$72.52
$2.48
(3.53%)
| Watchers | 533 |
| 52-Wk Low | $53.79 |
| 52-Wk High | $94.86 |
| Market Cap | $9.98B |
| Volume | 1.79M |
| 52-Wk High | $94.86 |
| 52-Wk Low | $53.79 |
Bruker Completes Asset Acquisition of NanoString BusinessBusiness Wire • about 9 hours ago
Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider...
Share to Feed
Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup (ELITech) for 870 million in cash, excluding the carved out ELITech clinical chemistry...
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2024. Brukers President and CEO Frank H. Laukien commented: Brukers first quarter 2024 was...
At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and...
Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and...
Bruker Corporation (Nasdaq: BRKR) today announced that it has entered into a definitive acquisition agreement with NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading...
Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR...
Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific...
Strategic partnership expands Biognosys' services to include Alamar's NULISA assays as well as joint scientific research in biofluid-based proteomicsComplementary value of Biognosys' DIA-MS unbiased...
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research Biognosys and Alamar Biosciences Forge Strategic Partnership in...